GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Current Liabilities

Alto Neuroscience (Alto Neuroscience) Other Current Liabilities : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Current Liabilities?

Alto Neuroscience's other current liabilities for the quarter that ended in Mar. 2024 was $0.00 Mil.

Alto Neuroscience's quarterly other current liabilities declined from Sep. 2023 ($0.19 Mil) to Dec. 2023 ($0.00 Mil) but then from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.00 Mil).

Alto Neuroscience's annual other current liabilities declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil).

Alto Neuroscience Other Current Liabilities Historical Data

The historical data trend for Alto Neuroscience's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Current Liabilities Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Other Current Liabilities
- - -

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial - - - - -

Alto Neuroscience Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Alto Neuroscience Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Current Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024